STOCK TITAN

Merus Global (BBCQ) reports 1.51M-share stake, 5.3% ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Bleichroeder Acquisition Corp. II Schedule 13G shows Merus Global Investments, LLC beneficially owns 1,510,876 shares of the issuer's Class A ordinary shares, representing 5.3% of the class. The filing ties that percentage to May 26, 2026, based on 28,750,000 shares outstanding reported in the issuer's Form F-4. The filing lists sole voting and sole dispositive power over the 1,510,876 shares and is signed by the filer’s General Counsel.

Positive

  • None.

Negative

  • None.

Insights

Merus reports a 5.3% passive stake with sole voting and dispositive power.

Merus Global Investments, LLC reports beneficial ownership of 1,510,876 shares, equal to 5.3% of the Class A ordinary shares, calculated from the issuer's stated 28,750,000 shares outstanding as of May 26, 2026. The filing is a standard Schedule 13G disclosure of position size and voting/dispositive authority.

Cash-flow treatment and intentions regarding holdings are not stated in the excerpt; subsequent filings would show any change in status or intent.

Filing documents sole voting/dispositive authority — governance relevance only.

The Schedule 13G explicitly shows Merus holds sole voting and sole dispositive power over the reported 1,510,876 shares. That indicates control over voting direction for this position but does not by itself indicate change in control or transaction activity.

Watch for future amendments that convert to a Schedule 13D or disclose acquisitions, dispositions, or arrangements affecting control.

Shares beneficially owned 1,510,876 shares reported by Merus Global Investments, LLC
Percent of class 5.3% calculated as of May 26, 2026
Shares outstanding 28,750,000 shares issuer-reported outstanding shares as of May 26, 2026 (Form F-4)
CUSIP G1170E104 Class A ordinary shares CUSIP
Filing signature date 06/05/2026 signature by General Counsel and Head of Compliance
Schedule 13G regulatory
"Item 1. (a) Name of issuer: Bleichroeder Acquisition Corp."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Item 4. (a) Amount beneficially owned: 1,510,876"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power corporate governance
"Item 4. (c)(iii) Sole power to dispose or to direct the disposition of: 1,510,876"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Form F-4 regulatory
"note: as reported by the Issuer in its Registration Statement on Form F-4"
Form F-4 is an official filing with the U.S. Securities and Exchange Commission used by non-U.S. companies when they offer securities in connection with mergers, acquisitions, exchange offers or similar transactions. It acts like a detailed product label or instruction manual that explains the deal, the securities being offered, financials, risks and voting requirements, and it matters to investors because it provides the essential facts needed to evaluate how the transaction could affect ownership, value and future returns.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G1170E104

(CUSIP Number)
05/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Row 11: Calculated based on the 28,750,000 shares of the Class A ordinary shares, par value $0.0001 per share, of Bleichroeder Acquisition Corp. II (the "Issuer") outstanding as of May 26, 2026, as reported by the Issuer in its Registration Statement on Form F-4, filed with the Securities and Exchange Commission on May 26, 2026.


SCHEDULE 13G



Merus Global Investments, LLC
Signature:/s/ Amrita M. Mahabaleswara
Name/Title:Amrita M. Mahabaleswara, General Counsel and Head of Compliance
Date:06/05/2026

FAQ

What stake does Merus Global Investments report in BBCQ?

Merus Global Investments reports beneficial ownership of 1,510,876 shares, representing 5.3% of Class A ordinary shares as calculated from 28,750,000 shares outstanding as of May 26, 2026.

Does Merus have voting control over the shares reported in the Schedule 13G?

Yes. The filing states Merus has sole voting power and sole dispositive power over the reported 1,510,876 shares, indicating authority to vote and direct disposition of those shares.

What date is used to calculate the 5.3% ownership in the filing?

The percentage is calculated using the issuer’s stated outstanding share count of 28,750,000 as of May 26, 2026, per the filing note that cites the issuer’s Form F-4.

Who signed the Schedule 13G for Merus Global Investments?

The filing is signed by Amrita M. Mahabaleswara, identified as General Counsel and Head of Compliance, with a signature date of June 5, 2026.

Does this Schedule 13G disclose Merus’s intent to influence Bleichroeder Acquisition Corp. II?

No intent language is included in the excerpt. The filing lists ownership and voting/dispositive power but does not state plans to influence management or seek control.